Your browser doesn't support javascript.
loading
Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Fedoriw, Andrew; Shi, Leilei; O'Brien, Shane; Smitheman, Kimberly N; Wang, Yunfei; Hou, Jiakai; Sherk, Christian; Rajapurkar, Satyajit; Laraio, Jenny; Williams, Leila J; Xu, Chunyu; Han, Guangchun; Feng, Qin; Bedford, Mark T; Wang, Linghua; Barbash, Olena; Kruger, Ryan G; Hwu, Patrick; Mohammad, Helai P; Peng, Weiyi.
Afiliação
  • Fedoriw A; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Shi L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • O'Brien S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Smitheman KN; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Wang Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hou J; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
  • Sherk C; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Rajapurkar S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Laraio J; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Williams LJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Xu C; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
  • Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feng Q; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
  • Bedford MT; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas.
  • Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Barbash O; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Kruger RG; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mohammad HP; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Peng W; Department of Biology and Biochemistry, University of Houston, Houston, Texas.
Cancer Immunol Res ; 10(4): 420-436, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35181787
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína-Arginina N-Metiltransferases / Peptídeos e Proteínas de Sinalização Intracelular Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína-Arginina N-Metiltransferases / Peptídeos e Proteínas de Sinalização Intracelular Limite: Animals / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2022 Tipo de documento: Article